Terminal component of complement C9 in CSF and plasma of patients with MS and aseptic meningitis.
A sensitive sandwich ELISA was applied to the measurement of the terminal component of complement C9 in CSF and plasma from 40 tension headache patients (reference group), 33 affected by clinically definite MS and 10 by aseptic meningitis. The levels of C9 in plasma were increased in aseptic meningitis. The determinations of CSF/plasma C9 ratio and C9 index, equal to (CSF C9/plasma C9): (CSF albumin/plasma albumin), thus accounting for changes of plasma C9 levels as well as damaged blood brain barrier, documented the existence of local consumption of C9 in aseptic meningitis. In contrast, only borderline alterations were evident in MS. The results indicate that local consumption of total C9 in CSF is an additional variable reflecting an acute inflammation within the CNS, but not demonstrable in MS, a chronic inflammatory CNS disorder.
Halawa
I
I
Department of Neurology, Karolinska Institute, Huddinge Hospital, Stockholm, Sweden.
Lolli
F
F
Link
H
H
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D003186:Complement C9 / Q000032:analysis / Q000134:cerebrospinal fluid*; D005260:Female; D006261:Headache / Q000097:blood / Q000134:cerebrospinal fluid / Q000276:immunology; D006801:Humans; D008297:Male; D008581:Meningitis / Q000276:immunology*; D008582:Meningitis, Aseptic / Q000097:blood / Q000134:cerebrospinal fluid / Q000276:immunology*; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000097:blood / Q000134:cerebrospinal fluid / Q000276:immunology*
D003186:Complement C9